Patients prioritise quantified, centre-specific risk information and use it to balance the cosmetic benefits of TOETVA against mental nerve morbidity and the wound risks of open surgery, supporting routine integration of audited complication rates into shared decision-making.
Zhang et al. (Sun,) studied this question.